AU2016209422B2 - Tissue matrices with controlled porosity or mechanical properties - Google Patents

Tissue matrices with controlled porosity or mechanical properties Download PDF

Info

Publication number
AU2016209422B2
AU2016209422B2 AU2016209422A AU2016209422A AU2016209422B2 AU 2016209422 B2 AU2016209422 B2 AU 2016209422B2 AU 2016209422 A AU2016209422 A AU 2016209422A AU 2016209422 A AU2016209422 A AU 2016209422A AU 2016209422 B2 AU2016209422 B2 AU 2016209422B2
Authority
AU
Australia
Prior art keywords
tissue
linking
cross
matrix
porous sponge
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2016209422A
Other languages
English (en)
Other versions
AU2016209422A1 (en
Inventor
Israel Jessop
Patrick Leamy
Mrinal Shah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LifeCell Corp
Original Assignee
LifeCell Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LifeCell Corp filed Critical LifeCell Corp
Publication of AU2016209422A1 publication Critical patent/AU2016209422A1/en
Application granted granted Critical
Publication of AU2016209422B2 publication Critical patent/AU2016209422B2/en
Priority to AU2020204357A priority Critical patent/AU2020204357A1/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
AU2016209422A 2015-01-21 2016-01-20 Tissue matrices with controlled porosity or mechanical properties Ceased AU2016209422B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2020204357A AU2020204357A1 (en) 2015-01-21 2020-06-30 Tissue matrices with controlled porosity or mechanical properties

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562105971P 2015-01-21 2015-01-21
US62/105,971 2015-01-21
US201562148532P 2015-04-16 2015-04-16
US62/148,532 2015-04-16
PCT/US2016/014009 WO2016118558A1 (en) 2015-01-21 2016-01-20 Tissue matrices with controlled porosity or mechanical properties

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2020204357A Division AU2020204357A1 (en) 2015-01-21 2020-06-30 Tissue matrices with controlled porosity or mechanical properties

Publications (2)

Publication Number Publication Date
AU2016209422A1 AU2016209422A1 (en) 2017-08-03
AU2016209422B2 true AU2016209422B2 (en) 2020-04-16

Family

ID=55300794

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2016209422A Ceased AU2016209422B2 (en) 2015-01-21 2016-01-20 Tissue matrices with controlled porosity or mechanical properties
AU2020204357A Abandoned AU2020204357A1 (en) 2015-01-21 2020-06-30 Tissue matrices with controlled porosity or mechanical properties

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2020204357A Abandoned AU2020204357A1 (en) 2015-01-21 2020-06-30 Tissue matrices with controlled porosity or mechanical properties

Country Status (9)

Country Link
US (3) US20160206784A1 (enExample)
EP (2) EP3795186A1 (enExample)
JP (1) JP7307527B2 (enExample)
CN (1) CN107206125A (enExample)
AU (2) AU2016209422B2 (enExample)
CA (1) CA2974120A1 (enExample)
DK (1) DK3247413T3 (enExample)
ES (1) ES2857028T3 (enExample)
WO (1) WO2016118558A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
JP6772390B2 (ja) * 2017-03-06 2020-10-21 ティーイーアイ バイオサイエンシズ，インコーポレイテッド 穿孔された組織移植片
CN108404195A (zh) * 2018-04-22 2018-08-17 代清燕 一种抗菌性促皮肤伤口愈合敷料及其制备方法
KR102955766B1 (ko) 2018-05-03 2026-04-22 콜플랜트 리미티드 진피 충전제 및 이의 적용
KR101938263B1 (ko) * 2018-07-31 2019-01-14 강호창 치과용 이중구조 멤브레인의 제조방법
JP2023552293A (ja) * 2020-12-10 2023-12-15 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブライ ユニバーシティー オブ エルサレム リミテッド 脱細胞化組織／ポリマーマルチコンポーネント生体材料
CN114366857A (zh) * 2022-02-08 2022-04-19 博纳格科技(天津)有限公司 一种可降解人工骨复合材料的制备方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1216717A1 (en) * 2000-12-21 2002-06-26 Ethicon, Inc. Reinforced tissue implants and methods of manufacture and use
WO2010059783A2 (en) * 2008-11-21 2010-05-27 Lifecell Corporation Reinforced biologic material
WO2011019822A2 (en) * 2009-08-11 2011-02-17 The Johns Hopkins University Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products
US20110238167A1 (en) * 2010-03-23 2011-09-29 Dove Jeffrey S Methods of conditioning sheet bioprosthetic tissue
WO2012017415A2 (en) * 2010-08-05 2012-02-09 Lifebond Ltd. Dry composition wound dressings and adhesives
US20140088701A1 (en) * 2012-09-26 2014-03-27 Lifecell Corporation Processed Adipose Tissue
US20140220095A1 (en) * 2013-02-06 2014-08-07 Lifecell Corporation Methods for Localized Modification of Tissue Products

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8735A (en) 1852-02-17 John oaed
US54A (en) 1836-10-15 Art of managing and supplying fie-e for generating steam in locomotive
US5709934A (en) * 1994-11-22 1998-01-20 Tissue Engineering, Inc. Bipolymer foams having extracellular matrix particulates
US5980738A (en) * 1995-10-04 1999-11-09 Monsanta Company Porous polymeric biosupports
JP4968976B2 (ja) * 1998-03-06 2012-07-04 慶彦 清水 コラーゲン材及びその製法
US6933326B1 (en) * 1998-06-19 2005-08-23 Lifecell Coporation Particulate acellular tissue matrix
US20080286242A2 (en) * 1999-11-05 2008-11-20 Donald Kleinsek Augmentation and repair of spincter defects with cells including mesenchymal cells
CA2412012C (en) * 2001-11-20 2011-08-02 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Resorbable extracellular matrix containing collagen i and collagen ii for reconstruction of cartilage
US7597885B2 (en) * 2004-03-26 2009-10-06 Aderans Research Institute, Inc. Tissue engineered biomimetic hair follicle graft
JP2007177074A (ja) * 2005-12-28 2007-07-12 Tohoku Univ 組成物およびその製造方法
EP2015707B1 (en) * 2006-05-09 2019-01-23 LifeCell Corporation Reinforced biological tissue
DE112007001197T5 (de) * 2006-05-16 2009-04-16 Purdue Research Foundation, West Lafayette Dreidimensionale gereinigte Kollagenmatrices
WO2008134541A2 (en) * 2007-04-25 2008-11-06 Musculoskeletal Transplant Foundation Reinforced biological mesh for surgical reinforcement
CN100531808C (zh) * 2007-04-28 2009-08-26 徐志飞 可降解的软组织修补片
DK3473260T3 (da) * 2007-07-10 2020-12-21 Lifecell Corp Acellulære vævsmatrixs-sammensætninger til vævsreparation
US8735054B1 (en) 2008-01-04 2014-05-27 Lifecell Corporation Acellular tissue matrix preservation solution
AU2009256193B2 (en) 2008-06-06 2015-04-23 Lifecell Corporation Elastase treatment of tissue matrices
AU2011232374B2 (en) * 2010-03-25 2015-06-25 Lifecell Corporation Preparation of regenerative tissue scaffolds
US20120040013A1 (en) * 2010-08-10 2012-02-16 LifeCell Corporation. Regenerative Tissue Scaffolds
EP3851131A1 (en) 2011-05-31 2021-07-21 LifeCell Corporation Adipose tissue matrices

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1216717A1 (en) * 2000-12-21 2002-06-26 Ethicon, Inc. Reinforced tissue implants and methods of manufacture and use
WO2010059783A2 (en) * 2008-11-21 2010-05-27 Lifecell Corporation Reinforced biologic material
WO2011019822A2 (en) * 2009-08-11 2011-02-17 The Johns Hopkins University Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products
US20110238167A1 (en) * 2010-03-23 2011-09-29 Dove Jeffrey S Methods of conditioning sheet bioprosthetic tissue
WO2012017415A2 (en) * 2010-08-05 2012-02-09 Lifebond Ltd. Dry composition wound dressings and adhesives
US20140088701A1 (en) * 2012-09-26 2014-03-27 Lifecell Corporation Processed Adipose Tissue
US20140220095A1 (en) * 2013-02-06 2014-08-07 Lifecell Corporation Methods for Localized Modification of Tissue Products

Also Published As

Publication number Publication date
EP3247413B1 (en) 2020-11-25
AU2016209422A1 (en) 2017-08-03
JP2018504206A (ja) 2018-02-15
EP3795186A1 (en) 2021-03-24
US20160206784A1 (en) 2016-07-21
WO2016118558A1 (en) 2016-07-28
US20250387535A1 (en) 2025-12-25
US20230063323A1 (en) 2023-03-02
ES2857028T3 (es) 2021-09-28
JP7307527B2 (ja) 2023-07-12
AU2020204357A1 (en) 2020-07-16
CN107206125A (zh) 2017-09-26
CA2974120A1 (en) 2016-07-28
EP3247413A1 (en) 2017-11-29
DK3247413T3 (da) 2021-03-01
HK1246212A1 (zh) 2018-09-07

Similar Documents

Publication Publication Date Title
US20250387535A1 (en) Tissue matrices with controlled porosity or mechanical properties
JP7559144B2 (ja) 脂肪組織製品および製造方法
EP3501558B1 (en) Flowable tissue products
CA3012849A1 (en) Biologic breast implant
US11633521B2 (en) Biologic breast implant
AU2017292652A1 (en) Tissue matrices incorporating multiple tissue types
AU2012355463A1 (en) Sheet tissue products
US20260053619A9 (en) Soft tissue supports, and methods of making and using same
HK1246212B (en) Tissue matrices with controlled porosity or mechanical properties
JP2026076164A (ja) トロポエラスチンを含む脂肪組織マトリックス

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired